Ligand validation:6RVC

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6RVC designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6RVC_NAG_A_1101	70%	43%	0.108	0.924	0.7	1.49	-	3	0	0	100%	1
6RVC_NAG_C_1101	34%	35%	0.178	0.859	0.52	2.02	-	6	0	0	100%	1
6RTW_NAG_A_502	55%	52%	0.143	0.911	0.38	1.43	-	3	0	0	100%	1
6RTX_NAG_A_502	31%	73%	0.162	0.828	0.35	0.69	-	-	0	0	100%	1
6RTY_NAG_A_502	30%	39%	0.146	0.805	0.28	2.06	-	5	0	0	100%	1
7DDF_NAG_B_401	100%	87%	0.02	0.992	0.21	0.47	-	-	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1
5O5D_NAG_B_501	100%	64%	0.02	0.995	0.38	0.97	-	1	0	0	100%	1
5LDS_NAG_A_1016	100%	70%	0.021	0.995	0.52	0.64	-	-	2	0	100%	1
5F9W_NAG_G_505	100%	86%	0.023	0.994	0.21	0.5	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.